生物股份 (600201.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

32.4x

EV/EBITDA

34.1x

Market Cap

CNY 13.67B

MomentumView details →

1D Return

−1.74%

YTD Return

−18.38%

RSI (14)

41.7

ValuationView details →

P/E (Fwd)

32.4x

EV/EBITDA

34.1x

Market Cap

CNY 13.67B

RSI (14)

41.7

MomentumView details →

1D Return

−1.74%

YTD Return

−18.38%

ProfitabilityView details →

Gross Margin

53.27%

Net Margin

7.49%

EBITDA Margin

26.13%

ROE (TTM)

1.91%

ROA (TTM)

1.60%

Asset Turnover

0.21x

GrowthView details →

Revenue YoY

+10.50%

EPS YoY

+30.41%

FCF YoY

−23.30%

Revenue CAGR 3Y

−2.97%

EPS CAGR 3Y

−22.05%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.02

EPS Surprise

−90.07%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.08

Avg Surprise (4Q)

−90.07%

Rev Surprise

−19.98%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.66x

Quick Ratio

3.26x

Div Yield

0.30%

Div Rate

CNY 0.04

Div Growth 1Y

+23.33%

Financials snapshotView financials →

Revenue (TTM)

1.39B

Net Income (TTM)

104.27M

Op. CF (TTM)

301.31M

Next earningsNov 4, 2026 →

Latest newsMore news →

No recent news for 600201.SH.

Similar companies

Summit Therapeutics Inc.SMMT 迈威生物-U688062.SH BridgeBio Pharma, Inc.BBIO BioMarin Pharmaceutical Inc.BMRN Exelixis, Inc.EXEL Nanjing Leads Biolabs Co Ltd09887.HK Find similar companies →

Latest newsMore news →

No recent news for 600201.SH.